Trading investing in small-cap indices is showing

Trading investing in small-cap indices is showing resilience, with Russell 2000 futures breaking key resistance. Risk appetite appears firm among speculative traders seeking higher beta exposure. A looming patent cliff presents another challenge for Pfizer. However, the company has multiple drugs with fast-growing sales that should largely offset any revenue declines from patent expirations. Pfizer's business development deals and pipeline progress should also help boost sales and profits. We set the standard with our unparalleled trading platform, enabling entrepreneurs, innovators, and investors to raise the capital they need to change the world. We want to share our vision for good governance, transparency, and trust with our listed community, furthering the responsible development of global business. You work too hard to list anywhere else. Learn more Financial sector trading investing saw renewed buying after major banks beat earnings estimates, driven by strong net interest margins despite rate stabilization.